GM1 ganglioside enhances Ret signaling in striatum

Journal of Neurochemistry

Volumn 130, Issue 4, 2014, Pages 541-554

  Newburn, Erin N ^a   Duchemin, Anne Marie ^a   Neff, Norton H ^a   Hadjiconstantinou, Maria ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

GDNF; GFR 1; GM1; PI3 kinase; Ret; Src

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; GANGLIOSIDE GM1; GDNF FAMILY RECEPTOR ALPHA; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN RET; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG MECHANISM; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEUROTROPISM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

GDNF; GFRΑ1; GM1; PI3 KINASE; RET; SRC;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BLOTTING, WESTERN; DOPAMINE; G(M1) GANGLIOSIDE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; IMMUNOPRECIPITATION; MALE; MICE; NEOSTRIATUM; ONCOGENE PROTEIN V-AKT; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-RET; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 84905746902     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12760     Document Type: Article

References (85)

1. Airaksinen M., and, Saarma M., (2002) The GDNF family: signaling, biological functions and therapeutic value. Nature Rev. Neurosci. 3, 383-394.
2. Alberti L., Borrello M. G., Ghizzoni S., Torriti F., Rizzett M. G., and, Pierotti M. A., (1998) Grb2 binding to the different isoforms of Ret tyrosine kinase. Oncogene 17, 1079-1087.
3. Bain J., Plater L., Elliott M., Shapiro N., Hastie C. J., McLauchlan H., Klevernic I., Arthur J. S. C., Alessi R. A., and, Cohen P., (2007) The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297-315.
4. Bespalov M. M., and, Saarma M., (2007) GDNF family receptor complexes are emerging drug targets. Trends Pharmacol. Sci. 28, 68-74.
5. Besset V., Scott R. P., and, Ibanez C. F., (2000) Signaling complexes and protein-protein interactions are involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase. J. Biol. Chem. 275, 39159-39166.
6. Bjorge J. D., Jakymiw A., and, Fujits D. J., (2000) Selected glimpses into the activation and function of Src kinases. Oncogene 19, 5620-5635.
7. Bohn M. C., (1999) A commentary on glial cell line-derived neurotrophic factor (GDNF). From A glial secreted molecule to gene therapy. Biochem. Pharmacol. 57, 135-142.
8. Brown M. T., and, Cooper J. A., (1996) Regulation, substrates and function of src. Biochim. Biophys. Acta 1287, 121-149.
9. Caré B. R., and, Soula H. A., (2011) Impact of receptor clustering on ligand binding. CMC Systems Biology 5, 48.
10. Carlomagno F., Vitagliano D., Guida T., Napolitano M., Vecchio G., Fusco A., Gazit A., Levitzki A., and, Santoro M., (2002) The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes. Cancer Res. 62, 1077-1082.
11. Carlomagno F., Vitsagliano D., Guida T., Basolo F., Castellone M. D., Melillo R. M., Fusco A., and, Santoro M., (2003) Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro- phrnyl0-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). J. Clin. Endo. Metabol. 88, 1897-1902.
12. Carniti C., Perego C., Mondellini P., Picrotti M. A., and, Bongarzone I., (2003) PP1 inhibitor induces degradation of RETMEN2A and RETMEN2B oncoproteins through proteosomal targeting. Cancer Res. 63, 2234-2243.
13. Cik M., Masure S., Lasage A. S. J., Van der Linden I., Van Gompel P., Pangalos M. N., Gordon R. D., and, Leysen J. E., (2000) Binding of GDNF and neurturin to human GDNF family receptor α1 and α2. J. Biol. Chem. 275, 27505-27512.
14. Coulpier M., Anders J., and, Ibanez C. F., (2002) Coordinated activation of autophosphorylation sites in the RET receptor tyrosine kinase. J. Biol. Chem. 277, 1991-1999.
15. De Vita G., Melillo R. M., Carlomagno F., Visconti R., Castellone M. D., Bellacosa A., Billaud M., Fusco A., Tsichlis P. N., and, Santoro M., (2000) Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 survival. Cancer Res. 60, 3727-3731.
16. Duchemin A. M., Ren Q., Mo L., Neff N. H., and, Hadjiconstantinou M., (2002) GM1 ganglioside induces phosphorylation and activation of Trk and Erk in brain. J. Neurochem. 81, 696-707.
17. Duchemin A. M., Ren Q., Neff N. H., and, Hadjiconstantinou M., (2008) GM1-induced activation of phosphatidylinositol 3-kinase: involvement of Trk receptors. J. Neurochem. 104, 2466-1477.
18. Duchemin A. M., Zhang H., Neff N. H., and, Hadjiconstantinou M., (2009) Increased expression of VMAT2 in dopaminergic neurons during nicotine withdrawal. Neurosci. Lett. 467, 182-186.
19. Durbec P., Marcos-Gutierrez C., Kilkenny C., et al,. (1996) GDNF signaling through the Ret receptor tyrosine kinase. Nature 381, 789-793.
20. Eketjall S., Fainzilber M., Murray-Rust J., and, Ibanez C. F., (1999) Distinct structural elements in GDNF mediate binding to GFRα1 and activation of the GFRα1-c-Ret receptor complex. EMBO J. 18, 5901-5910.
21. Encinas M., Tansey M., Tsui-Pierchala B., Comella J., Milbrandt J., and, Johnson E. M., Jr, (2001) c-Src is required for glial cell line-derived neurotrophic factor (GDNF) family ligand mediated neuronal survival via a phosphatidylinositol 3-kinase (PI-3K)-dependent pathway. J. Neurosci. 21, 1464-1472.
22. Encinas M., Crowder R., Milbrandt J., and, Johnson E. M., Jr, (2004) Tyrosine 981, a novel Ret autophosphorylation site, binds c-src to mediate neuronal survival. J. Biol. Chem. 279, 18262-18269.
23. Esposito C. L., D'Alessio A., de Franciscis V., and, Cerchia L., (2008) A cross-talk between TrkB and Ret tyrosine kinases receptors mediates neuroblastoma cell differentiation. PLoS ONE 3, e1643.
24. Fantini J., and, Barrantes F. J., (2009) Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function. Biochim. Biophys. Acta 1788, 2345-2361.
25. Goettl V. M., Wemlinger T. A., Duchemin A. M., Neff N. H., and, Hadjiconstantinou M., (1999) GM1 ganglioside restores dopaminergic neurochemical and morphological markers in aged rats. Neuroscience 92, 991-1000.
26. Goettl V. M., Welinger T. A., Fong T. G., Neff N. H., and, Hadjiconstantinou M., (2000) Retinal cholinergic and dopaminergic deficits of aged rats are improved following treatment with GM1 ganglioside. Brain Res. 877, 1-6.
27. Goettl V. M., Neff N. H., and, Hadjiconstantinou M., (2002) Sciatic nerve axotomy in aged rats: response of motoneurons and the effect of GM1 ganglioside treatment. Brain Res. 968, 44-53.
28. Goettl V. M., Zhang H., Burrows A. C., Wemlinger T. A., Neff N. H., and, Hadjiconstantinou M., (2003) GM1 enhances dopaminergic markers in the brain of aged rats. Exp. Neurol. 183, 665-672.
29. Golden J., Baloh R., Kotzbauer P., Lampe P., Osborne P., Milbrandt J., and, Johnson E. M., Jr, (1998) Expression of neurturin, GDNF, and their receptors in the adult mouse CNS. J. Comp. Neurol. 398, 139-150.
30. Hadjiconstantinou M., and, Neff N. H., (1988) Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-treated mouse. J. Neurochem. 51, 1190-1196.
31. Hadjiconstantinou M., and, Neff N. H., (1998) GM1 ganglioside: in vivo and in vitro trophic actions on central neurotransmitter systems. J. Neurochem. 70, 1335-1345.
32. Hadjiconstantinou M., and, Neff N. H., (2000) GM1 ganglioside: Commonalities of action with neurotrophins, in Neurobiology of the Neurotrophins, (, Mocchetti I., ed.), pp. 427-453. FP Graham Publishing Co., Johnson City, TN.
33. Hadjiconstantinou M., Rosetti Z., Paxton R., and, Neff N. H., (1986) Administration of GM1 ganglioside restores the dopamine content in striatum after chronic treatment with MPTP. Neuropharmacol. 25, 1075-1077.
34. Hadjiconstantinou M., Mariani A., and, Neff N. H., (1989) GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study. Brain Res. 484, 297-303.
35. Hadjiconstantinou M., Newburn E., and, Neff N. H., (2010) Ret phosphorylation and activation by GM1. ASN Abstracts. Neurodegenerative diseases, Ab PTW06. American Society for Neurochemistry, Santa Fe, NM.
36. Hanke J. H., Gardner J. P., Dow R. L., Changelian P. S., Brissette W. H., Weringer E. J., Pollok B. A., and, Connelly P. A., (1996) Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study on Lck- and Fyn-dependent T cell activation. J. Biol. Chem. 271, 695-701.
37. Hayashi H., Ichihara M., Murakami H., et al,. (2000) Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor. Oncogene 19, 4469-4475.
38. Holtzman D. M., Kilbridge J., Li Y., Cunningham E. T., Lenn N. J., Clary D. O., Reichardt L. F., and, Mobley W. C., (1995) TrkA expression in the CNS: Evidence for the existence of several novel NGF-responsive CNS neurons. J. Neurosci. 15, 1567-1578.
39. Ibanez C. F., (2013) Structure and physiology of the RET receptor tyrosine kinase. Cold Spring Harb. Perspect. Biol. 5, a009134.
40. Jing S., Wen D., Yu Y., et al,. (1996) GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell 85, 1113-1124.
41. Jing S., Yu Y., Fang M., Hu Z., Holst P. L., Boone T., Delaney J., Schultz H., Zhou R., and, Fox G. M., (1997) GFRalpha-2 and GFRalpha-3 are two new receptors for ligands of the GDNF family. J. Biol. Chem. 272, 33111-33317.
42. Kasahara K., and, Sanai Y., (2000) Functional roles of glycosphingolipids in signal transduction via lipid rafts. Glycoconjugate J. 17, 153-162.
43. Knowles P. P., Rust-Murray J., Kjaer S., Scott R. P., Hanrahan S., Santoro M., Ibanez C. F., and, McDonald N. Q., (2006) Structure and chemical inhibition of the RET tyrosine kinase domain. J. Biol. Chem. 282, 33577-33587.
44. Kordower J. H., and, Bjorklund A., (2013) Trophic factor gene therapy for Parkinson's disease. Mov. Disord. 28, 96-109.
45. Lamballe F., Smeyne R. J., and, Barbacid M., (1994) Developmental expression of trkC, the neurotrophin-3 receptor, in the mammalian nervous system. J. Neurosci. 14, 14-28.
46. Lin L., Doherty D., Lile J., Bektesh S., and, Collins F., (1993) GDNF: a glial cell line derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132.
47. Loberto N., Prioni S., Prinetti A., Ottico E., Chigomo V., Karagogeos D., and, Sonnino S., (2003) The adhesion protein TAG-1 has a ganglioside environment in the sphingolipid-enriched membrane domains of neuronal cells in culture. J. Neurochem. 85, 224-233.
48. Martinez Ferrando I., Chaerkady R., Zhong J., et al,. (2012) Identification of targets of cSrc tyrosine kinase by chemical complementation and phosphoproteomics. Mol. Cell. Proteomics 11, 355-369.
49. Mo L., Ren Q., Duchemin A. M., Neff N. H., and, Hadjiconstantinou M., (2005) GM1 and Erk signaling in the aged brain. Brain Res. 1054, 125-134.
50. Mocchetti I., (2005) Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins. Cell. Mol. Life Sci. 62, 2283-2294.
51. Mologni L., Sala E., Riva B., Cesaro L., Cazzaniga S., Redaelli S., Marin O., Pasquato N., Donella-Deana A., and, Gambacorti-Passerini C., (2005) Expression, purification, and inhibition of human RET tyrosine kinase. Protein Exp. Purif. 41, 177-185.
52. Mutoh T., Tokuda A., Miyadai T., Hamaguchi M., and, Fujiki N., (1995) Ganglioside GM1 binds to the Trk protein and regulates receptor function. Proc. Natl Acad. Sci. USA 92, 5087-5091.
53. Newburn E. N., Hadjiconstantinou M., and, Neff N. H., (2005) Activation of Ret by GM1 ganglioside. Society for Neuroscience Abstracts. Program No 338.4, Abstract Viewer/Itinerary Planner. Society for Neuroscience, Washington, DC.
54. Newburn E. N., Hadjiconstantinou M., and, Neff N. H., (2007) GM1 signaling through the GDNF receptor complex. Society for Neuroscience Abstracts. Program No 254.6 Abstract viewer/Itinerary planner. Society for Neuroscience, San Diego, CA.
55. Nishio M., Fukumoto S., Furukawa K., Ichimura A., Miyazaky H., Kusunoki S., Urano T., and, Furukawa K., (2004) Overexpressed GM1 suppresses nerve growth factor (NGF) signals by modulating the intracellular localization of NGF receptors and membrane fluidity in PC12 cells. J. Biol. Chem. 279, 33368-33378.
56. Nosrat C. A., Tomac A., Hoffer B., and, Olson L., (1997) Cellular and developmental patterns of expression of Ret and glial cell line-derived neurotrophic factor receptor alpha mRNAs. Exp. Brain Res. 115, 410-422.
57. Numan S., and, Serrogy K. B., (1999) Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study. J. Comp. Neurol. 403, 295-308.
58. Paratcha G., Ledda F., Baars L., Coulpier M., Besset V., Anders J., Scott R., and, Ibanez C. F., (2001) Released GFRα1 potentiates downstream signaling, neuronal survival, and differentiation via a novel mechanism of recruitment of c-Ret to lipid rafts. Neuron 29, 171-184.
59. Pierchala B. A., Tsui C. C., Milbrandt J., and, Johnson E. M., (2007) NGF augments the autophopshorylation of Ret via inhibition of ubiquitin-dependent degradation. J. Neurochem. 100, 1169-1176.
60. Pong K., Xu R. Y., Baron W. F., Louis J. C., and, Beck K. D., (1998) Inhibition of phosphatidylinositol 3-kinase activity blocks cellular differentiation mediated by glial cell line-derived neurotrophic factor in dopaminergic neurons. J. Neurochem. 71, 1912-1919.
61. Posse de Chaves E., and, Sipione S., (2010) Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction. FEBS Lett. 584, 1748-1759.
62. Prinetti A., Iwabuchi K., and, Hakomori S., (1999) Glycosphingolipid- enriched signaling domain in mouse neuroblastoma neuro2a cells. J. Biol. Chem. 274, 20916-20924.
63. Prioni S., Mauri L., Loberto N., Casellato R., Chigorno V., Karagogeos D., Prinetti A., and, Sonnino S., (2004) Interactions between gangliosides and proteins in the exoplasmic leaflet of neuronal plasma membranes: a study performed with tritium-labeled GM1 derivative containing a photoactivable group linked to the oligosaccharide chain. Glycoconjugate J. 21, 461-470.
64. Qiao S., Iwashita T., Furukawa T., Yamamoto M., Sobue G., and, Takahashi M., (2001) Differential effects of leucocyte common antigen-related protein on biochemical and biological activities of RET-MEN2A and RET-MEN2B mutant proteins. J. Biol. Chem. 276, 9460-9467.
65. Rabin S. J., Bacchis A., and, Mochetti I., (2002) Gangliosides activate Trk receptors by inducing the release of neurotrophins. J. Biol. Chem. 277, 49466-49472.
66. Runeberg-Roos P., and, Saarma M., (2007) Neurotrophic factor receptor Ret: structure, cell biology, and inherited diseases. Ann. Med. 39, 572-580.
67. Sarabi A., Hoffer B., Olson L., and, Morales M., (2001) GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area. J. Comp. Neurol. 441, 106-117.
68. Sariola H., and, Saarma M., (2003) Novel functions and signaling pathways for GDNF. J. Cell. Science 116, 3855-3862.
69. Sawada H., Ibi M., Urushitani M., Nakahishi M., Akaike A., and, Shimohama S., (2000) Neuroprotective mechanism of glia cell line-derived neurotrophic factor in mesencephalic neurons. J. Neurochem. 74, 1175-1184.
70. Shwarzmann G., (2001) Uptake and metabolism of exogenous glycosphingolipids by cultured cells. Cell Devel. Biol. 12, 163-171.
71. Sobreviella T., Clary D. O., Reichardt L. F., Brandabur M. M., Kordower J. H., and, Mufson E. J., (1994) TrkA-immunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin. J. Comp. Neurol. 350, 587-611.
72. Sonnino S., Pronetti A., Mauri L., and, Tettamanti G., (2006) Dynamic and structural properties of sphingolipids as driving force to the formation of membrane domains. Chem. Rev. 106, 2111-2125.
73. Sullivan A. M., and, Toulouse A., (2011) Neurotrophic factors for the treatment of Parkinson's disease. Cytokines & Growth Factors Reviews 22, 157-165.
74. Takahashi M., Asai N., Iwashita T., Isomura T., Miyazaki K., and, Matsuyama M., (1993) Characterization of the ret proto-oncogene products expressed in mouse L cells. Oncogene 8, 2925-2929.
75. Tansey M., Baloh R., Millbrandt J., and, Johnson E. M., Jr, (2000) GFRα1-mediated localization of Ret to lipid rafts is required for effective downstream signaling, differentiation, and neuronal survival. Neuron 25, 611-623.
76. Treanor J. J., Goodman L., de Sauvage F., et al,. (1996) Characterization of a multicomponent receptor for GDNF. Nature 382, 80-83.
77. Trupp M., Arenas E., Fainzilber M., et al,. (1996) Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381, 785-789.
78. Trupp M., Belluardo N., Funakoshi H., and, Ibanez C. F., (1997) Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret oncogene, and GDNF receptor-α indicates multiple mechanisms of trophic actions in the adult rat CNS. J. Neurosci. 17, 3554-3567.
79. Trupp M., Scott R., Whittemore S. R., and, Ibanez C. F., (1999) Ret-dependent and -independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells. J. Biol. Chem. 274, 20885-20894.
80. Tsui-Pierchala B. A., Ahrens R. C., Crowder R. J., Milbtrandt J., and, Johnson E. M., Jr, (2002a) The Long and short isoforms of Ret function as independent signaling complexes. J. Biol. Chem. 277, 34618-34625.
81. Tsui-Pierchala B. A., Milbrandt J., and, Johnson E. M., Jr, (2002b) NGF utilizes c-Ret via a novel GFL-independent, inter-RTK, signaling mechanism to maintain the trophic status of mature sympathetic neurons. Neuron 33, 261-273.
82. Uehara Y., Fukazawa H., Murakami Y., and, Mizuno S., (1989) Irreversible inhibition of V-Src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds. Biochem. Biophys. Res. Comm. 163, 803-809.
83. Ugarte S. D., Lin E., Klann E., Zigmond M. J., and, Perez R. G., (2003) Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK. J. Neurosci. Res. 73, 105-112.
84. Wang X., (2013) Structural studies of GDNF family ligands with their receptors-Insights into ligand recognition and activation of receptor tyrosine kinase Ret. Biochim. Biophys. Acta 1834, 2205-2212.
85. Weihmuller F. B., Hadjiconstantinou M., Bruno J. P., and, Neff N. H., (1988) Administration of GM1 ganglioside eliminates neuroleptic-induced sensorimotor deficits in MPTP-treated mice. Neurosci. Lett. 92, 207-212.